Clinical Cancer Research: 2 (9)

Alteration of p53 damage response by tamoxifen treatment.

C Guillot, N Falette, S Courtois, T Voeltzel, E Garcia, M Ozturk and A Puisieux

Clin Cancer Res September 1 1996 2 (9) 1439-1444;
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.

J T Pinto, B P Suffoletto, T M Berzin, C H Qiao, S Lin, W P Tong, F May, B Mukherjee and W D Heston

Clin Cancer Res September 1 1996 2 (9) 1445-1451;
Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.

H D Preisler, V M Kotelnikov, S LaFollette, S Taylor 4th, S Mundle, N Wood, J S Coon 4th, J Hutchinson, W Panje, D D Caldarelli and K Griem

Clin Cancer Res September 1 1996 2 (9) 1453-1460;
Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.

F M Muggia, X Wu, D Spicer, S Groshen, S Jeffers, C G Leichman, L Leichman and K K Chan

Clin Cancer Res September 1 1996 2 (9) 1461-1467;
Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial.

K H Link, M Kornmann, G H Leder, U Butzer, J Pillasch, L Staib, F Gansauge and H G Beger

Clin Cancer Res September 1 1996 2 (9) 1469-1474;
Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.

J L Marshall, E Richmond and R J DeLap

Clin Cancer Res September 1 1996 2 (9) 1475-1480;
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.

L W Anderson, T L Chen, O M Colvin, L B Grochow, J M Collins, M J Kennedy and J M Strong

Clin Cancer Res September 1 1996 2 (9) 1481-1487;
Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor.

J L Abbruzzese, T Madden, S M Sugarman, A L Ellis, S Loughlin, K R Hess, R A Newman, L A Zwelling and M N Raber

Clin Cancer Res September 1 1996 2 (9) 1489-1497;
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.

H S Chan, G DeBoer, J J Thiessen, A Budning, J E Kingston, J M O'Brien, G Koren, E Giesbrecht, G Haddad, Z Verjee, J L Hungerford, V Ling and B L Gallie

Clin Cancer Res September 1 1996 2 (9) 1499-1508;
Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy.

J D Bitran, B Samuels, Y Trujillo, L Klein, L Schroeder and J Martinec

Clin Cancer Res September 1 1996 2 (9) 1509-1513;
Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients.

S Lundgren, S I Helle and P E Lonning

Clin Cancer Res September 1 1996 2 (9) 1515-1521;
Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.

U Scherf, I Benhar, K O Webber, I Pastan and U Brinkmann

Clin Cancer Res September 1 1996 2 (9) 1523-1531;
Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinoside.

Y Messinger, Y Yanishevski, V I Avramis, O Ek, L M Chelstrom, R Gunther, D E Myers, J D Irvin, W Evans and F M Uckun

Clin Cancer Res September 1 1996 2 (9) 1533-1542;
The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases.

B Dezso, G P Haas, F Hamzavi, S Kim, E J Montecillo, P D Benson, J E Pontes, R L Maughan and G G Hillman

Clin Cancer Res September 1 1996 2 (9) 1543-1552;
Trisomy 7 by dual-color fluorescence in situ hybridization: a potential biological marker for prostate cancer progression.

R Y Wang, P Troncoso, J L Palmer, A K El-Naggar and J C Liang

Clin Cancer Res September 1 1996 2 (9) 1553-1558;
Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.

S M Emadian, J D McDonald, S C Gerken and D Fults

Clin Cancer Res September 1 1996 2 (9) 1559-1564;
Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?

A Gerl, R Lamerz, C Clemm, K Mann, R Hartenstein and W Wilmanns

Clin Cancer Res September 1 1996 2 (9) 1565-1570;
Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells.

A A Elbendary, F D Cirisano, A C Evans Jr, P L Davis, J D Iglehart, J R Marks and A Berchuck

Clin Cancer Res September 1 1996 2 (9) 1571-1575;
Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer.

O Gallo, I Chiarelli, S Bianchi, A Calzolari, L Simonetti and B Porfirio

Clin Cancer Res September 1 1996 2 (9) 1577-1582;
Replication errors in hematological neoplasias: genomic instability in progression of disease is different among different types of leukemia.

J H Ohyashiki, K Ohyashiki, S Aizawa, K Kawakubo, T Shimamoto, H Iwama, S Hayashi and K Toyama

Clin Cancer Res September 1 1996 2 (9) 1583-1589;
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.

O Caffo, C Doglioni, S Veronese, M Bonzanini, A Marchetti, F Buttitta, P Fina, R Leek, L Morelli, P D Palma, A L Harris and M Barbareschi

Clin Cancer Res September 1 1996 2 (9) 1591-1599;
Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.

C Noviello, F Courjal and C Theillet

Clin Cancer Res September 1 1996 2 (9) 1601-1606;
Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.

V Abetamann, H F Kern and H P Elsässer

Clin Cancer Res September 1 1996 2 (9) 1607-1618;
Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma.

J Li, Y Yang, T Fujie, K Baba, H Ueo, M Mori and T Akiyoshi

Clin Cancer Res September 1 1996 2 (9) 1619-1625;
Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.

C A Pettaway, S Pathak, G Greene, E Ramirez, M R Wilson, J J Killion and I J Fidler

Clin Cancer Res September 1 1996 2 (9) 1627-1636;

Main menu

User menu

Search

Table of Contents

Articles

Info for

About Clinical Cancer Research